Hostname: page-component-76fb5796d-x4r87 Total loading time: 0 Render date: 2024-04-26T13:23:58.566Z Has data issue: false hasContentIssue false
  • English
  • Français

Validation of the French version of the BACS (the brief assessment of cognition in schizophrenia) among 50 French schizophrenic patients

Published online by Cambridge University Press:  16 April 2007

Marie-Cécile Bralet ,
Bruno Falissard ,
Xavier Neveu ,
Margaret Lucas-Ross ,
Anne-Marie Eskenazi  and
Richard S.E. Keefe
Marie-Cécile Bralet*
Affiliation:
Department of Psychiatry (Fitz-James 5), Clermont de l’Oise, Mental Health Hospital, 2 rue des Finets, 60600Clermont de l’Oise, France Inserm Research Unit U669 (PSIGIAM, «Paris Sud Innovation Group in Adolescent Mental Health»), University of Paris XI, AP-HP, Maison de Solenn, 97 boulevard de Port-Royal, 75679Paris cedex 14, France
Bruno Falissard
Affiliation:
Inserm Research Unit U669 (PSIGIAM, «Paris Sud Innovation Group in Adolescent Mental Health»), University of Paris XI, AP-HP, Maison de Solenn, 97 boulevard de Port-Royal, 75679Paris cedex 14, France
Xavier Neveu
Affiliation:
Inserm Research Unit U669 (PSIGIAM, «Paris Sud Innovation Group in Adolescent Mental Health»), University of Paris XI, AP-HP, Maison de Solenn, 97 boulevard de Port-Royal, 75679Paris cedex 14, France
Margaret Lucas-Ross
Affiliation:
Department of Psychiatry (Fitz-James 5), Clermont de l’Oise, Mental Health Hospital, 2 rue des Finets, 60600Clermont de l’Oise, France
Anne-Marie Eskenazi
Affiliation:
Department of Psychiatry (Fitz-James 5), Clermont de l’Oise, Mental Health Hospital, 2 rue des Finets, 60600Clermont de l’Oise, France
Richard S.E. Keefe
Affiliation:
Duke University Medical Center, Box 3270, Durham, NC27710, USA
*
∗Corresponding author. Department of Psychiatry (FJ 5), CHI Clermont de l'Oise, 2 rue des Finets, 60600 Clermont de l'Oise, France. Tel.: +33 615 738 111; fax: +33 344 775 084. E-mail address: mariemarthebralet@yahoo.fr (M.-C. Bralet).
Get access

Abstract

Schizophrenic patients demonstrate impairments in several key dimensions of cognition. These impairments are correlated with important aspects of functional outcome. While assessment of these cognition disorders is increasingly becoming a part of clinical and research practice in schizophrenia, there is no standard and easily administered test battery. The BACS (Brief Assessment of Cognition in Schizophrenia) has been validated in English language [Keefe RSE, Golberg TE, Harvey PD, Gold JM, Poe MP, Coughenour L. The Brief Assessment of Cognition in Schizophrenia: reliability, sensibility, and comparison with a standard neurocognitive battery. Schizophr. Res 2004;68:283–97], and was found to be as sensitive to cognitive dysfunction as a standard battery of tests, with the advantage of requiring less than 35 min to complete. We developed a French adaptation of the BACS and this study tested its ease of administration and concurrent validity. Correlation analyses between the BACS (version A) and a standard battery were performed. A sample of 50 stable schizophrenic patients received the French Version A of the BACS in a first session, and in a second session a standard battery. All the patients completed each of the subtests of the French BACS . The mean duration of completion for the BACS French version was 36 min (S.D. = 5.56). A correlation analysis between the BACS (version A) global score and the standard battery global score showed a significant result (r = 0.81, p < 0.0001). The correlation analysis between the BACS (version A) sub-scores and the standard battery sub-scores showed significant results for verbal memory, working memory, verbal fluency, attention and speed of information processing and executive functions (p < 0.001) and for motor speed (p < 0.05). The French Version of the BACS is easier to use in French schizophrenic patients compared to a standard battery (administration shorter and completion rate better) and its good psychometric properties suggest that the French Version of the BACS may be a useful tool for assessing cognition in schizophrenic patients with French as their primary language.

Keywords

SchizophreniaCognitionPrognosisAssessmentBACS
Type
Original article
Information
European Psychiatry , Volume 22 , Issue 6 , September 2007 , pp. 365 - 370
Copyright
Copyright © Elsevier Masson SAS 2007

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Addington, J.Cognitive functioning and negative symptoms in schizophrenia. In: Sharma, T., Harvey, P.D. editors. Cognition in schizophrenia Oxford: Oxford University Press; 2000. p. 193–209.Google Scholar
Addington, J., Addington, D., Maticka-tyndale, E.Cognitive functioning and positive and negative symptoms in schizophrenia. Schizophr Res 1991;4:123–134.CrossRefGoogle Scholar
Bilder, R.M., Lipshitz-Broch, L., Reiter, G.Intellectual deficits in first episode schizophrenia: evidence for progressive deterioration. Schizophr Bull 1992;18:437–448.CrossRefGoogle ScholarPubMed
Bleuler, E.Dementia praecox or the group of schizophrenia. New York: International Universities Press; 1950.Google Scholar
Breier, A., Schreiber, J.L., Dyer, J., Pickar, D.National Institute of Mental Health follow-up study of schizophrenia: prognosis and predictors of outcome. Arch Gen Psychiatry 1991;48:239–246.CrossRefGoogle ScholarPubMed
Bromley, E.A collaborative approach to targeted treatment development for schizophrenia: a qualitative evaluation of the NIMH-MATRICS project. Schizophr Bull 2005;31(4):954–961.CrossRefGoogle ScholarPubMed
Buchanan, R.W., Davis, M., Goff, D., Green, M.F., Keefe, R.S.E., Leon, A.C.et al.A summary of the FDA-NIMH-MATRICS Workshop on Clinical Trial Design for Neurocognitive Drugs for Schizophrenia. Schizophr Bull 2005;31(1):5–19.CrossRefGoogle Scholar
Davidson, M., Harvey, P.D., Powchik, P., Parrella, M., White, L., Knobler, H.Y.et al.Severity of symptoms in chronically institutionalized geriatric schizophrenic patients. Am J Psychiatry 1995;152:197–207.Google ScholarPubMed
Dickerson, F., Boronow, J.J., Ringel, N., Parente, F.Social functioning and neurocognitive deficits in outpatients with schizophrenia: a 2 year follow-up. Schizophr Res 04 May 1994;37(1):13–20.CrossRefGoogle Scholar
Frith, C.D., Baddely, A.D., Henderson, L.The cognitive neuropsychology of schizophrenia. UK: Psychology Press; 1992.Google Scholar
Goldberg, T.E., Torrey, E.F., Gold, J.M., Ragland, J.D., Bigelow, L.B., Weinberger, D.R.Learning and memory in monozygotic twins discordant for schizophrenia. Psychol Med 1993;23:71–85.CrossRefGoogle Scholar
Green, M.F.What are the functional consequences of neurocognitive deficits in schizophrenia?. Am J Psychiatry 1996;153:321–330.Google Scholar
Green, M.F., Satz, P., Ganzell, S., Vaclav, J.F.Wisconsin card sorting performance in schizophrenia: remediation of a stubborn deficit. Am J Psychiatry 1992;149:62–67.Google ScholarPubMed
Green, M.F., Kern, R.S., Braff, D.L., Mintz, J.Neurocognitive deficits and functional outcome in schizophrenia: are we measuring the “right stuff”. Schizophr Bull 2000;26(1):119–136.CrossRefGoogle ScholarPubMed
Hardy-Bayle, M.C., Sarfati, Y., Passerieux, C.The cognitive basis of disorganization symptomatology in schizophrenia and its clinical correlates: toward a pathogenetic approach to disorganization. Schizophr Bull 2003;29(3):459–471.CrossRefGoogle Scholar
Harvey, P.D.Reality monitoring in mania and schizophrenia: the association between thought disorder and performance. J Nerv Ment Dis 1985;173:67–73.CrossRefGoogle ScholarPubMed
Harvey, P.D., Keefe, R.S.E.Cognitive impairment in schizophrenia and implications atypical neuroleptic treatment. CNS Spectr 1997;2:1–11.Google Scholar
Harvey, P.D., Keefe, R.S.E.Studies of cognitive change with treatment in schizophrenia. Am J Psychiatry 2001;158:176–184.CrossRefGoogle Scholar
Harvey, P.D., Sharma, T.Cognition in schizophrenia: impairments, importance and treatment strategies. Oxford Univ. Press; 2000.Google Scholar
Harvey, P.D., Docherty, N.M., Serper, M.R., Rasmussen, M.Cognitive deficits and thought disorder. II. An eight-month follow-up study. Schizophr Bull 1990;16:147–156.CrossRefGoogle Scholar
Harvey, P.D., Lombardi, J., Leibman, M., White, L., Parrella, M., Powchik, P.et al.Cognitive impairment and negative symptoms in schizophrenia: a prospective study of their relationship. Schizophr Res 1996;22:223–231.CrossRefGoogle Scholar
Harvey, P.D., Howanitz, E., Parrella, M., White, L., Davidson, M., Mohs, R.C.et al.Symptoms, cognitive functioning, and adaptative skills in geriatric patients with lifelong schizophrenia: a comparison across treatment. Am J Psychiatry 1998;155:1080–1086.CrossRefGoogle Scholar
Harvey, P.D., Silverman, J.M., Mohs, R.C., Parrella, M., White, L., Powchik, P.et al.Cognitive decline in late-life schizophrenia: a longitudinal study of geriatric chronically hospitalized patients. Biol Psychiatry 1999;45:32–40.CrossRefGoogle ScholarPubMed
Harvey, P.D., Parrella, M., White, L., Mohs, R.E., Davidson, M., Davis, K.L.Convergence of cognitive and adaptive decline in late-life schizophrenia. Schizophr Res 1999;35:77–84.CrossRefGoogle ScholarPubMed
Heaton, R.K.Wisconsin card sorting test manual. Odessa, FL: Psychological Assessment Resources; 1993.Google Scholar
Heinrichs, R.W., Zakzanis, K.K.Neurocognitive deficit in schizophrenia: a quantitative review of the evidence. Neuropsychology 1998;12(3):426–445.CrossRefGoogle Scholar
Hemsley, D.R.Apr. Schizophrenia: a cognitive model and its implications for psychological intervention. Behav Modif 1996;20(2):139–169.CrossRefGoogle ScholarPubMed
Hoff, A.L., Sakuma, M., Weineke, M., Horon, R., Kushmer, M., Delisi, L.E.Longitudinal neuropsychological follow-up study of first episode schizophrenia. Am J Psychiatry Sept 1999;156:1336–1341.Google ScholarPubMed
Horn, J.L.A rationale and test for the number of factors in factor analysis. Psychometrica 1965;30:179–185.CrossRefGoogle ScholarPubMed
Keefe, R.S.E.The contribution of neuropsychology to psychiatry. Am J Psychiatry 1995;152:6–15.Google ScholarPubMed
Keefe, R.S.E., Golberg, T.E., Harvey, P.D., Gold, J.M., Poe, M.P., Coughenour, L.The Brief Assessment of Cognition in Schizophrenia: reliability, sensibility, and comparison with a standard neurocognitive battery. Schizophr Res 2004;68:283–297.CrossRefGoogle Scholar
Kern, R.S., Green, M.F., Nuechterlein, K.H., Deng, B.H.NIMH-MATRICS survey on assessment of neurocognition in schizophrenia. Schizophr Res 2004;72:11–19.CrossRefGoogle Scholar
Kraepelin, E.Dementia praecox and paraphrenia. Edinburgh: E&S Livingstone; 1919.Google Scholar
Kurtz, M.M.Aug. Neurocognitive rehabilitation for schizophrenia. Curr Psychiatry Rep 2003;5(4):303–310 Review.CrossRefGoogle Scholar
Leffe, J.P., Thornicroft, G., Coxhead, N., Trieman, N.The TAPS Project. 22: a five-year follow-up of long stay psychiatric patients discharged to the community. Br J Psychiatry 1994;165(Suppl. 25):13–17.CrossRefGoogle Scholar
Lezac, M.Neuropsychological assessment. 4th ed.New York: Oxford Univ. Press; 2004.Google Scholar
Nuechterlein, K.H., Edell, W.S., Norris, M., Dawson, M.E.Attentional vulnerability indicators, thought disorder, and negative symptoms. Schizophr Bull 1986;12:408–426.CrossRefGoogle ScholarPubMed
Nuechterlein, K.H., Barch, D.M., Gold, J.M., Goldberg, T.E., Green, M.F., Heaton, R.K.Identification of separable cognitive factors in schizophrenia. Schizophr Res. 15 Dec. 2004;72(1):29–39.CrossRefGoogle Scholar
Perlick, D., Mattis, S., Stanstny, T., Teresi, J.Neuropsychological discriminators of long-term inpatient or outpatient status in chronic schizophrenia. J Neuropsychiatry Clin Neurosci 1992;4:428–434.Google ScholarPubMed
Saykin, A.J., Gur, R.C., Gur, R.E., Mozley, P.D., Mozley, L.H., Resnick, S.M.et al.Neuropsychological function in schizophrenia. Selective impairment in memory and learning. Arch Gen Psychiatry 1991;48(7):618–624.CrossRefGoogle ScholarPubMed
Saykin, A.J., Shtasel, D.L., Gur, R.E., Kester, D.B., Mozley, L.H., Stafiniak, P.et al.Neuropsychological deficits in neuroleptic naive patients with first episode schizophrenia. Arch Gen Psychiatry 1994;51:124–131.CrossRefGoogle ScholarPubMed
Wechsler, D.Wechsler Adult Intelligence Scale. 3rd ed.San Antonio, TX: Psychological; 1997. WAIS-III.Google Scholar
Wechsler, D.Wechsler Memory Scale. 3rd ed. 1997 San Antonio, TX: Psychological; WMS-III.Google Scholar
Weickert, T.W., Goldberg, T.E., Gold, J.M., Bigelow, L.B., Egan, M.F., Weinberger, D.R.Cognitive impairments in patients with schizophrenia displaying preserved and compromised intellect. Arch Gen Psychiatry 2000;57:907–913.CrossRefGoogle ScholarPubMed
Submit a response

Comments

No Comments have been published for this article.